GlaxoSmithKline (GSK) has agreed to acquire Nuvalent for $10.6 billion, the companies said, in a deal designed to strengthen the buyer’s cancer pipeline with Nuvalent’s precision oncology ...

The team used the computing power of the MareNostrum series of supercomputers to analyze public genomic data spanning biodiversity as a whole.

Symeres has already seen strong interest from clients seeking enabling formulation solutions for poorly soluble compounds.

This nucleic acid amplification technique detects 180 mycoplasma species at single-copy sensitivity for biologics testing.

ReiThera’s gorilla-derived adenovirus platform combines innate tumor selectivity, low seroprevalence, and systemic-delivery advantages.

Biopharma companies are embracing pre-use post-sterilization integrity testing in line with stricter GMP requirements.

This report is intended to inform discussion and decision making, not to prescribe solutions. Produced in collaboration with GEN, it reflects the collective voice of an industry adapting to new ...

Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.

Incyte has agreed to acquire Vega Therapeutics for up to $2 billion, the companies said, in a deal designed to bolster the buyer’s hematology pipeline with antibody assets led by VGA039, a Phase III ...

A complete wiring diagram of all the connections between the fruit fly brain and "spinal cord" provides translational ...

Antiretroviral therapy (ART) has enabled most people living with HIV to live long and healthy lives. However, a small portion of people experience detectable traces of the virus, known as ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.